左西孟旦在各种病因所致急性心力衰竭患者的现代治疗中的应用。
Levosimendan in the modern treatment of patients with acute heart failure of various aetiologies.
作者信息
Glinka Lidia, Mayzner-Zawadzka Ewa, Onichimowski Dariusz, Jalali Rakesh, Glinka Maciej
机构信息
2 Anaesthesiology and Intensive Care Clinical Ward, Clinical University Hospital, Department of Anaesthesiology and Intensive Care, University of Warmia and Mazury, Olsztyn, Poland.
1 Clinical Department of Anaesthesiology and Intensive Care, Regional Specialist Hospital, Olsztyn, Poland.
出版信息
Arch Med Sci. 2019 Nov 7;17(2):296-303. doi: 10.5114/aoms.2018.77055. eCollection 2021.
Abstract
Acute decompensated heart failure (ADHF) is a common clinical problem associated with a high mortality rate. Because ADHF has various aetiologies, there are a range of therapeutic options, among others, positive inotropes (inotropic drugs). As an inotropic agent whose mechanism is different than that of "classical" medicines, levosimendan (LSM) is one of the most common therapeutic options. Despite many publications on LSM, some issues related to its application remain unclear. The authors of this paper have attempted to summarise expert recommendations and reports available in the literature.
摘要
急性失代偿性心力衰竭（ADHF）是一个常见的临床问题，死亡率很高。由于ADHF有多种病因，因此有一系列治疗选择，其中包括正性肌力药（强心药）。左西孟旦（LSM）作为一种作用机制与“传统”药物不同的强心剂，是最常用的治疗选择之一。尽管有许多关于LSM的出版物，但其应用的一些问题仍不明确。本文作者试图总结文献中可用的专家建议和报告。
相似文献
1
Levosimendan in the modern treatment of patients with acute heart failure of various aetiologies.左西孟旦在各种病因所致急性心力衰竭患者的现代治疗中的应用。
Arch Med Sci. 2019 Nov 7;17(2):296-303. doi: 10.5114/aoms.2018.77055. eCollection 2021.
2
Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects.左西孟旦的药理学：变力、血管扩张和心脏保护作用。
J Clin Pharm Ther. 2013 Oct;38(5):341-9. doi: 10.1111/jcpt.12067. Epub 2013 Apr 18.
3
Effect of levosimendan in patients with acute decompensated heart failure : A meta-analysis.左西孟旦对急性失代偿性心力衰竭患者的影响：一项荟萃分析。
Herz. 2019 Nov;44(7):630-636. doi: 10.1007/s00059-018-4693-3. Epub 2018 Apr 10.
4
Levosimendan: a review of its use in the management of acute decompensated heart failure.左西孟旦：急性失代偿性心力衰竭治疗应用综述
Drugs. 2003;63(23):2651-71. doi: 10.2165/00003495-200363230-00009.
5
Current drugs and medical treatment algorithms in the management of acute decompensated heart failure.急性失代偿性心力衰竭管理中的当前药物及医学治疗方案
Expert Opin Investig Drugs. 2009 Jun;18(6):695-707. doi: 10.1517/13543780902922660.
6
The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.左西孟旦与多巴酚丁胺对比及联合应用于失代偿性心力衰竭治疗的研究
Expert Opin Pharmacother. 2007 Apr;8(5):665-77. doi: 10.1517/14656566.8.5.665.
7
Levosimendan: beyond its simple inotropic effect in heart failure.左西孟旦：超越其在心力衰竭中单纯的正性肌力作用。
Pharmacol Ther. 2007 May;114(2):184-97. doi: 10.1016/j.pharmthera.2007.01.008. Epub 2007 Feb 16.
8
Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine.左西孟旦联合多巴酚丁胺治疗对多巴酚丁胺难治的急性失代偿性心力衰竭
J Clin Med. 2020 Nov 9;9(11):3605. doi: 10.3390/jcm9113605.
9
Advances in chemical pharmacotherapy for managing acute decompensated heart failure.急性失代偿性心力衰竭化学药物治疗的进展
Expert Opin Pharmacother. 2017 Apr;18(5):471-485. doi: 10.1080/14656566.2017.1299708. Epub 2017 Mar 5.
10
Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.左西孟旦对急性失代偿性心力衰竭患者短期临床病程的影响。
JACC Heart Fail. 2013 Apr;1(2):103-11. doi: 10.1016/j.jchf.2012.12.004. Epub 2013 Apr 1.
引用本文的文献
1
Effect of Levosimendan Use on All-Cause Mortality in Out-of-Hospital Cardiac Arrest Survivors After Extracorporeal Cardiopulmonary Resuscitation.左西孟旦用于体外心肺复苏后院外心脏骤停幸存者全因死亡率的影响
Biomedicines. 2025 Apr 13;13(4):955. doi: 10.3390/biomedicines13040955.
2
Role of inhaled levosimendan in peripartum cardiomyopathy.吸入性左西孟旦在围产期心肌病中的作用。
Saudi J Anaesth. 2022 Oct-Dec;16(4):500-503. doi: 10.4103/sja.sja_297_22. Epub 2022 Sep 3.
本文引用的文献
1
Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis.左西孟旦用于预防脓毒症急性器官功能障碍
N Engl J Med. 2016 Oct 27;375(17):1638-1648. doi: 10.1056/NEJMoa1609409. Epub 2016 Oct 5.
2
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗工作组编写，欧洲心脏病学会心力衰竭协会（HFA）提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
3
Role of levosimendan in the management of subarachnoid hemorrhage.左西孟旦在蛛网膜下腔出血治疗中的作用。
Am J Emerg Med. 2016 Feb;34(2):298-306. doi: 10.1016/j.ajem.2015.11.024. Epub 2015 Nov 25.
4
Neurogenic stunned myocardium - do we consider this diagnosis in patients with acute central nervous system injury and acute heart failure?神经源性 stunned 心肌——我们是否应该在急性中枢神经系统损伤和急性心力衰竭患者中考虑这一诊断？
Anaesthesiol Intensive Ther. 2015;47(2):175-80. doi: 10.5603/AIT.2015.0017.
5
Early administration of levosimendan is associated with improved kidney function after cardiac surgery - a retrospective analysis.心脏手术后早期使用左西孟旦与肾功能改善相关——一项回顾性分析
J Cardiothorac Surg. 2014 Nov 18;9:167. doi: 10.1186/s13019-014-0167-8.
6
Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure.早期使用左西孟旦可能改善蛛网膜下腔出血合并急性心力衰竭患者的预后。
Int J Cardiol. 2014 Oct 20;176(3):1435-7. doi: 10.1016/j.ijcard.2014.08.039. Epub 2014 Aug 13.
7
Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus.重复使用左西孟旦治疗慢性晚期心力衰竭：临床证据、实际考虑和观点：专家小组共识。
Int J Cardiol. 2014 Jun 15;174(2):360-7. doi: 10.1016/j.ijcard.2014.04.111. Epub 2014 Apr 18.
8
Levosimendan reverses right-heart failure in a 51-year-old patient after heart transplantation.左西孟旦逆转了一名51岁心脏移植患者的右心衰竭。
Wien Klin Wochenschr. 2014 Aug;126(15-16):495-9. doi: 10.1007/s00508-014-0528-2. Epub 2014 Mar 21.
9
Levosimendan improves renal function in acute decompensated heart failure: possible underlying mechanisms.左西孟旦改善急性失代偿性心力衰竭的肾功能：可能的潜在机制。
Eur J Heart Fail. 2014 Mar;16(3):281-8. doi: 10.1002/ejhf.9. Epub 2013 Dec 11.
10
Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials.间歇性左西孟旦可改善慢性心力衰竭患者的中期生存率：随机试验的荟萃分析。
Clin Res Cardiol. 2014 Jul;103(7):505-13. doi: 10.1007/s00392-013-0649-z. Epub 2013 Dec 25.
Zotero 插件